Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This is a conjugate vaccine antigen composed of the capsular polysaccharide from *Haemophilus influenzae* type b (Hib) covalently linked to an outer membrane protein complex derived from *Neisseria meningitidis*. The conjugation enhances immunogenicity, especially in infants and young children, by converting the polysaccharide into a T-cell dependent antigen. It is used in vaccines for prevention of invasive diseases caused by *Haemophilus influenzae* type b.
Induction of T-cell dependent antibody response against Hib polysaccharide
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Haemophilus influenzae type b capsular polysaccharide-conjugated outer membrane protein complex of Neisseria meningitidis.